Clinical Trial Supply

We are experts in global clinical trial supply,
packaging, labeling, storage, and distribution solutions

Comparator sourcing, medicines and ancillaries

Drug developers preparing for clinical trials require support to ensure that they have access to the necessary comparator and support medications, where and when patients need them. 

Benefits when outsourcing clinical trials: 

  • Strategic savings
  • Agility and flexibility
  • Trial-long, uninterrupted supply
  • Reduced lead times and overstock

    We provide strategic insights and global, comparator sourcing solutions to support your planning and comparator sourcing teams in their efforts to set up regulatory compliant, efficient, and value-adding clinical trials.

STRATEGIC CONSULTATION

SOURCING SOLUTIONS

PARTNERING WITH INCEPTUA FOR CLINICAL TRIALS

Our global logistics and distribution network for clinical manufacturing allows us to operate across borders and ensure supplies reach trial sites on time. We are aligned with the needs of your company and the patients who depend on us working effectively together. Inceptua’s global coverage and market leading support worldwide means one-stop control and visibility of your studies’ requirements. 

Key Account Management and governance plans tailored to your needs ensure that your requirements will always be our priority.

One-Stop-Shop – Strategic Value for Clients

Sourcing – Storing – Packaging – Labeling – Distributing – Destructing
Key Strenghts

 

  • IMP and Co-Medication Supply Chain Solutions
  • Strategic Consulting from Global Expert Team
  • Dedicated Resources
  • Optimized Sourcing, Manufacturing and Distribution Strategy
  • Quick Quotations
  • No More Waiting In Line!
  • Site Ordering & Inventory Management Solution
  • Central Pharmacy Model
Client Value

 

  • Strategic Cost Savings
  • Reduced Lead Times and Overstock
  • Agility and Flexibility
  • Trial-Long, Uninterrupted Supply
  • Single Strategic Vendor Managing End-to-End IMP and Co-Medication Supply Chain
Experienced, Transparent, Easy-to-Work with, providing Innovative, Agile & Responsive Solutions

Inceptua are experts in comparator sourcing
across major and rare therapeutic areas

In 2023, Inceptua delivered over 500 medicines, benefitting over 100,000 patients across the world. ​

  • Breast Cancer
  • Colon Cancer 
  • Pancreatic Cancer 
  • Chronic Lymphocytic Leukemia (CCL)
  • Hodgkin Lymphoma
  • Prostate Cancer 
  • Wilms Tumor and other Pediatric Kidney Cancers
  • Multiple Myeloma
  • Testicular Cancer 
  • Chrohn’s Disease
  • Colic
  • High Cholesterol
  • Blood Clots (DVT)
  • Nutrition (parenteral nutrition PN)
  • COVID-19
  • Glucose, Saline, supplements and misc. diluents
  • Fungal infections
  • Thrombocytopeni
  • Non-Small Cell Lung Cancer
  • Myeloproliferative Neoplasms
  • Acute Lymphoblastic Leukemia (ALL)
  • Gastroesophageal Junction Cancer
  • Kaposi Sarcoma
  • Small Cell Lung Cancer
  • RCC
  • Meningeal Leukemia
  • Cervical Cancer 
  • Ulcerative Colitis
  • Plaque Psoriasis
  • Myocardial Infarction
  • Nausea
  • Diabetes
  • Asthma
  • Tuberculosis (TB)
  • Ancillaries
  • Inflammation
  • Other Vaccines
  • Ovarian, Fallopian, or Primary Peritoneal Cancer
  • Rectal Cancer
  • Bladder Cancer 
  • Head and Neck Cancers
  • Neuroblastoma / Globlastoma
  • Soft Tissue Sarcoma
  • HCC
  • Mantle Cell Lymphoma
  • Chronic Myeloid Leukemia
  • Psoriatic Arthritis
  • Pain indications
  • Acute Transplant Rejection
  • Cardiovascular Disease
  • Gestational Trophoblastic Neoplasia
  • Alzheimers Disease
  • Schizophrenia
  • Seizures
  • COPD
  • Acute Myeloid Leukemia (AML)
  • Stomach (Gastric) Cancer
  • Bone Cancer 
  • Bowel Cancer
  • Non-Hodgkin Lymphoma
  • Thyroid Cancer
  • Metastatic Melanoma
  • Myelofibrosis
  • Arthritis
  • Age-related Macular Degeneration (AMD)
  • Anemia
  • Macular (Dry Eye, AMD, RVO, DME, DR)
  • Blood Cancer
  • Brain Tumors
  • Influenza
  • Bacterial Infections
  • Idiopathic Pulmonary Fibrosis (IFP)

20+ years’ experience in oncology comparator sourcing

Since 1997 Inceptua’s multi-national Clinical Trial Services team has been helping clients optimize their oncology clinical trial supply. We have global reach and offices across the USA, Europe, and Asia to ensure that we can offer you the right sourcing solution and essential services exactly when and where you need it, with local support.

Packaging, labelling, storage, and distribution

We support with packaging, labelling, as well as storage and distribution:

MANUFACTURING SOLUTIONS

LOGISTICS/DISTRIBUTION

We have over 20 years’ experience of supplying clinical supplies to sponsors in over 50 countries, spanning all therapy areas.

We provide clinical trial supplies, from large volumes for late stage trials, to smaller quantities for pre-clinical phases. With significant experience sourcing in Europe, the Americas, and Asia, we help you find the best strategy to ensure you have access to the correct material, and an uninterrupted supply to ensure the needs of your patients are met.

Our customized solutions ensure that international borders are not a barrier to the continuation of your trial. With experience delivering into countries all over the world, our pragmatic approach to the unpredictable clinical supply chain environment will help you resolve potential issues before they even arise.

Any questions?

Ask our experts

About

Mark has 20 years of experience in clinical supplies, pre-approval access, and business development, and leads our strategic development.
EXECUTIVE VICE PRESIDENT
CLINICAL TRIAL SERVICES

Mark Ware

About

With a background in practicing medicine, Maria oversees all activity to ensure that patient safety remains at the core of our operations.
CHIEF MEDICAL OFFICER
INCEPTUA GROUP

Maria Eklind

About

Industry expert Annika leads our global supply chain and operations, and ensures best-in-class supply chain solutions for our clients.
EXECUTIVE VICE PRESIDENT
GLOBAL SUPPLY CHAIN AND QUALITY

Annika Kollén

About

Experienced in international business, logistics, and distribution management, Damian leads the operational activity for our Clinical Trial Services team.
OPERATIONS DIRECTOR,
CLINICAL TRIAL SERVICES

Damian Procak

We are here to help by
providing guidance and
reliable supply for clinical
trial sponsors.

BIO

CEO and Board Member

Stefan Fraenkel

Stefan Fraenkel is the CEO of the Inceptua Group and is also on the Inceptua Board. He has extensive experience in the pharmaceutical industry. Before joining Inceptua, he held senior management positions at Sobi (Swedish Orphan Biovitrum), Sweden’s largest publicly listed specialty pharmaceutical company, leading Marketing & Sales and serving as Head of Corporate Development and Strategy.

Previously, Stefan worked at Pfizer and Wyeth in international commercial leadership roles across Europe and the USA, gaining deep insights into global pharmaceutical markets and strategies. Stefan has also spent part of his career in management consulting. Stefan holds a PhD in International Economics, an MBA, and a BSc in Engineering.

BIO

Member of the Board

Chris Hasslinger

Chris Hasslinger is a Partner of Vesey Street Capital Partners and serves as a member of the Firm’s Investment Committee. He joined VSCP in 2023 and is responsible for sourcing and evaluating new investment opportunities and general portfolio company management. Mr. Hasslinger has nearly three decades of experience in healthcare and technology strategy and deal-making within the industry as well as in investment banking and private equity. He has extensive M&A experience, having closed over $20 billion in transaction value, and has established and structured a number of large commercial partnerships.

BIO

Executive Vice Chairman

Alan Raffensperger

Alan Raffensperger has a robust leadership background in the pharmaceutical industry, having served as CEO of Inceptua and COO of Sobi (Swedish Orphan Biovitrum), along with significant international executive roles at Amgen, Roche, and Pharmacia.

He has also been CEO for venture capital-owned medical device companies, showcasing his versatility in healthcare leadership. Alan’s early career as an advanced life support paramedic provided a strong foundation in emergency healthcare.

He holds an MBA and a BA in Emergency Health Care Management.

BIO

Member of the Board

Blake Goodner

Blake Goodner is a founder member of the investment firm Bridger Capital. He previously worked as a healthcare analyst at Tiger Management and a healthcare investment banker at Morgan Stanley. He currently serves as an advisor and board member for a range of healthcare companies. Mr. Goodner has been a member of the Trinity College Board of Visitors and the Duke Annual Fund Executive Committee. He is a current advisory board member with The Duke Margolis-Center for Health Policy.

BIO

Member of the Board

Adam Feinstein

Adam Feinstein is the Managing Partner of Vesey Street Capital Partners. Mr. Feinstein has 30 years of investment experience exclusively in the healthcare services sector. Prior to founding Vesey Street Capital Partners in 2014, he was a Managing Director on Wall Street and a healthcare industry executive. He held the position of Senior Vice President of Corporate Development, Strategic Investments, and Office of the Chief Executive Officer at LabCorp. Before his tenure at LabCorp, he spent 14 years as the Managing Director in Equity Research at Lehman Brothers/Barclays Capital. Mr. Feinstein is the Chairman of VSCP’s investment committee. He is also actively involved in working with portfolio company executives and sourcing new investment opportunities. At the same time, he oversees all of the firm’s investment activities and employees.

BIO

Member of the Board

Larry Marsh

Larry is a General Partner of Vesey Street Capital Partners and serves as a member of the Firm’s Investment Committee. He joined VSCP in 2016, and currently sits on the Board of QualityMetric, Safecor Health, and HRGi. He is responsible for portfolio company management and for evaluating new investment opportunities. Prior to VSCP, Larry was EVP, New Market Development & Chief Strategy Officer at Fortune 10 AmerisourceBergen. Prior to that, Larry was the #1 ranked Healthcare Technology & Distribution analyst on Wall Street for over a decade, at Barclays, Lehman Brothers, Salomon Smith Barney, and Wheat First Butcher & Singer. Larry worked with Adam, Bryan, Dan, and Joe at Barclays and Lehman. Larry received a B.S. in Economics & Management as well as an M.B.A. from the University of Richmond, and an M.P.H. from Columbia University.

BIO

Member of the Board

Heyward Donigan

Heyward Donigan is a seasoned healthcare CEO, Board Member, and Private Equity Advisor with broad industry experience and a track record of profitable growth. From 2019 to 2023, Ms. Donigan served as Rite Aid’s president and chief executive officer, making her one of the few women CEOs of a Fortune 500 company. While at Rite Aid, Ms. Donigan led the company to through a major brand, merchandise and technology transformation, debt reduction/refinancing, while also leading the company through a pandemic. Ms.Donigan is currently a strategic advisor to Vesey Street Capital Partners, Arima Health, and a board member of OnMed.

BIO

Executive Chairman

Doug Cook

Doug Cook is the Executive Chairman at Inceptua. Mr. Cook began his career driving the early success of Livingston Healthcare, leading to the purchase by UPS to become what is today UPS’s Global Healthcare business. After Livingston Healthcare, Mr. Cook moved to AmerisourceBergen (now called Cencora/COR) in 1998 and had an impressive career overseeing most of Cencora’s high growth, manufacturer-facing business. Mr. Cook ultimately served as the Executive Vice President, President Commercialization and Animal Health for COR.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.